HitGen
Chengdu
About HitGen
HitGen is provides biological reagents and services to support drug discovery research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $39.1M
- Funding stage: IPO
- Last round: Grant (Nov 2025)
- Ticker: sse:688222
- Website: hitgen.com
- Phone: +86 28 85197385
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hitgen-63755 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.